Grants and Contributions

Victims and Survivors of Crime Week will take place from May 11 to May 17, 2025. Victims and Survivors of Crime Week projects provide an opportunity to raise awareness about victim issues and about the programs, services and laws in place to help victims and survivors of crime and their families.

Demonstrate artificial intelligence technologies on commercial farms

This three-month project will make it possible to develop a complete project proposal. The proposed project will develop an implementation plan to create and implement a formal review and evaluation process for intimate partner and family violence screening, assessment and intervention tools available to service providers working with older women (65 and up).

This 60-month project will review, test and enhance assessment and intervention tools available to service providers working with older women (55+) who experience, or are at risk of experiencing, gender-based violence. Particular attention will be paid to older women from underserved groups and to the additional barriers they encounter. Through collaboration with a wide array of partner organizations, a series of promising practices will be developed and tested to respond to the unique needs of older survivors.

The objective of this funding opportunity is to support a knowledge synthesis network designed to collaborate and rapidly respond to the need for synthesized evidence across the full breadth of Canada's COVID-19 pandemic response (including public-health measures, clinical management, health-system arrangements, and economic and social impacts). Through a highly collaborative approach, the knowledge synthesis network is expected to:

-Produce rapid knowledge syntheses and associated evidence-based products (e.g., evidence profiles) related to the COVID-19 pandemic, based on current evidence and that responds to an identified evidence need;
-Provide decision-makers with high-quality, timely, accessible and relevant evidence for the rapid translation of knowledge into policy, practice and/or clinical guidelines to address the immediate response to the pandemic; and
-Address evidence gaps and build the evidence base for the response to COVID-19;
-Enhance national and international coordination across knowledge synthesis experts and organizations involved in producing COVID-19 related products.

This funding opportunity is expected to:
• Support the creation and/or further development of formal networks by encouraging national and international collaboration, resource sharing, capacity building and dissemination in priority research areas

The specific objectives of this funding opportunity are to:

• Develop a platform to support pediatric rare disease clinical trials in Canada in an accessible manner, for both the profit and not-for-profit sectors, to maximize the impact and benefit of the research for clinical practice, policy, and future research;
• Increase the capacity to perform rare disease clinical trials in Canada by offering training and mentorship opportunities for researchers, patients, clinicians and other relevant stakeholders;
• Attract international clinical trials, increasing investments in Canada and providing earlier access to innovative therapies to people living in Canada;
• Foster diversity and inclusion in and improve access to clinical trials;
• Implement processes to acquire data from clinical trials, real world registries, health economics evaluation, and post-marketing surveillance to inform assessment reviews throughout the whole drug/therapy cycle; and,
• Increase the number of new rare disease drug submissions for authorization of commercialization to Health Canada.

Develop and implement a strategic, outcome-oriented clinical trials research agenda to ensure alignment with current and emerging priorities in HIV, hepatitis C and/or other STBBIs and related health conditions; Sustain a high quality national infrastructure (including methodological expertise, data management and analysis, research support staff and regulatory expertise) to enable Canadian researchers to collaboratively and efficiently conduct innovative and excellent clinical trials and related research across Canada and internationally; Accelerate the translation and uptake of new knowledge into clinical applications and guidelines for patient care to support the adoption of best practices by clinicians, caregivers and patients; Engage stakeholders and partners (including people living with HIV, hepatitis C and/or other STBBIs; community organizations; Indigenous peoples; clinicians; policy makers; and relevant national networks) in CTN activities and governance committees to ensure their active and meaningful involvement; Strengthen Canadian research capacity to conduct and apply clinical research through training and mentoring initiatives; and Strengthen the networking and partnership strategies and secure additional funding to maximize the impact and outcomes of the Network and work toward sustainability.

Improve the identification of pathogenesis, prevention (including understanding and addressing underlying risk factors), detection and management of sepsis in Canada through coordinated national research activities across the CIHR research themes to generate new knowledge, technical and scientific expertise.
Accelerate the iterative, bi-directional translation of evidence into practice for improved patient experience and outcomes through coordinated multi-sectoral, multi-theme, and multi-disciplinary activities and knowledge sharing.
Develop and validate interventions that change significant aspects of practice; evaluate outcomes of implementation of interventions; and accelerate the translation of research discoveries and best and wise practices to bridge gaps between research outcomes and health impact.
Build and promote relevant research capacity, including training and early career development, by providing high-quality, multi-disciplinary training and mentoring through active engagement of established researchers, early-career investigators and trainees.

Improve the identification of pathogenesis, prevention (including understanding and addressing underlying risk factors), detection and management of sepsis in Canada through coordinated national research activities across the CIHR research themes to generate new knowledge, technical and scientific expertise.
Accelerate the iterative, bi-directional translation of evidence into practice for improved patient experience and outcomes through coordinated multi-sectoral, multi-theme, and multi-disciplinary activities and knowledge sharing.
Develop and validate interventions that change significant aspects of practice; evaluate outcomes of implementation of interventions; and accelerate the translation of research discoveries and best and wise practices to bridge gaps between research outcomes and health impact.
Build and promote relevant research capacity, including training and early career development, by providing high-quality, multi-disciplinary training and mentoring through active engagement of established researchers, early-career investigators and trainees.